Download the full-sized PDF
Permanent link (DOI): https://doi.org/10.7939/R3BD03
This file is in the following communities:
|Faculty of Graduate Studies and Research|
This file is in the following collections:
|Theses and Dissertations|
The effects of hyperlipidemia on the pharmacokinetic and pharmacodynamic aspects of amiodarone and ketoconazole Open Access
- Other title
- Type of item
- Degree grantor
University of Alberta
- Author or creator
El Sayed, Dalia
- Supervisor and department
Dr. Brocks, Dion R (Faculty of Pharmacy and Pharmaceutical Sciences
- Examining committee member and department
Dr. Jurasz, Paul (Faculty of Pharmacy and Pharmaceutical Sciences)
Dr. Marleau, Sylvie (Faculty of Pharmacy, University of Montreal)
Dr. Jamali, Fakhreddin (Faculty of Pharmacy and Pharmaceutical Sciences)
Dr. Baker, Glen (Department of Psychiatry)
Dr. Brocks,Dion R. (Faculty of Pharmacy and Pharmaceutical Sciences)
Dr. El-Kadi, Ayman (Faculty of Pharmacy and Pharmaceutical Sciences)
Faculty of Pharmacy and Pharmaceutical Sciences
- Date accepted
- Graduation date
Doctor of Philosophy
- Degree level
The influence of hyperlipidemia on the pharmacodynamic and pharmacokinetic aspects of lipophilic drugs was explored. The antiarrhythmic, amiodarone, and the antifungal, (±)-ketoconazole, were used as model drugs. Experimental hyperlipidemia was induced in rat using poloxamer 407 and two sensitive novel HPLC assays were developed.
In a multiple dosing study, hyperlipidemia increased amiodarone plasma concentrations, heart concentrations and electrocardiographic changes. The amiodarone heart uptake could not be totally attributed to its unbound fraction, where the cardiac very low density lipoprotein receptors seemed to play a role in the uptake of bound drug.
Amiodarone liver metabolism in presence and absence of hyperlipidemia was studied using isolated primary rat liver hepatocytes. The metabolism of amiodarone was lower in hepatocytes isolated from hyperlipidemic than those from normolipidemic rats. Hyperlipidemic serum resulted in a decrease in amiodarone metabolism and when coincubated, the expected decrease in unbound fraction seemed to resulted in greater inhibition of metabolism.
(±)-Ketoconazole showed stereoselectivity in its pharmacokinetics in rat with (+)-ketoconazole showing higher plasma concentrations than its antipode. This was attributed to its higher protein binding. There was no difference in the total bioavailability of the two enantiomers. Ketoconazole enantiomers exhibited nonlinear pharmacokinetics. In normolipidemic rat plasma ketoconazole enantiomers were more than 95% bound to lipoprotein deficient fraction. Hyperlipidemia resulted in shifting both enantiomers 20% to very low density and low density lipoprotein fractions.
In a pharmacokinetic assessment, hyperlipidemia was found to increase ketoconazole enantiomer volume of distribution. Moreover, the stereoselectivity ratios of most pharmacokinetic parameters were changed. After oral dosing, the uptake of (-)-ketoconazole was significantly decreased. Since ketoconazole is used as a potent CYP3A inhibitor, alteration in liver concentrations of (-)-ketoconazole, the more potent inhibitory enantiomer, could decrease its CYP inhibitory potential.
Hyperlipidemia potentiated the CYP-mediated interaction between ketoconazole and midazolam with significantly higher midazolam AUC and lower clearance. This was attributed to the inhibitory action of ketoconazole and the effect of hyperlipidemia on the binding of midazolam. Hyperlipidemia was found to unexpectedly decrease midazolam unbound fraction in plasma.
In conclusion, the findings could explain some unexpected dose versus effect outcomes in hyperlipidemic patients receiving amiodarone or ketoconazole.
- License granted by Dalia El Sayed (firstname.lastname@example.org) on 2010-09-23T19:42:56Z (GMT): Permission is hereby granted to the University of
Alberta Libraries to reproduce single copies of
this thesis and to lend or sell such copies for
private, scholarly or scientific research purposes
only. Where the thesis is converted to, or
otherwise made available in digital form, the
University of Alberta will advise potential users
of the thesis of the above terms.
The author reserves all other publication and
other rights in association with the copyright in
the thesis, and except as herein provided, neither
the thesis nor any substantial portion thereof may
be printed or otherwise reproduced in any material
form whatsoever without the author's prior written
- Citation for previous publication
- Date Uploaded
- Date Modified
- Audit Status
- Audits have not yet been run on this file.
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 2065445
Last modified: 2015:10:12 20:30:12-06:00
Filename: El Sayed_Dalia_Fall 2010.pdf
Original checksum: 181a7cb688c4e067010826dee734fd5a
Well formed: true
Status message: Invalid page tree node offset=5281
Status message: Outlines contain recursive references.
File title: title page
File title: Microsoft Word - title page
File author: user